Brief: Kintara Therapeutics Granted Extension By Nasdaq To Regain Compliance With The Stockholders' Equity Continued Listing Requirement
05/12/2023 15:54
Dec 5 (Reuters) - Kintara Therapeutics Inc KTRA.O :
* KINTARA THERAPEUTICS GRANTED EXTENSION BY NASDAQ TO REGAIN
COMPLIANCE WITH THE STOCKHOLDERS' EQUITY CONTINUED LISTING
REQUIREMENT
Source text for Eikon: ID:nPn5Y0Cnra
Further company coverage: KTRA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on TuHURA Biosciences
See all newsBrief: Tuhura Biosciences Receives Key U.S. Patent For Its Groundbreaking Delta Opioid Receptor Antibody Drug Conjugate Technology
TuHURA Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tuhura Biosciences Reports Second Quarter 2026 Financial Results And Provides A Corporate Update
TuHURA Biosciences Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Tuhura Biosciences Inc Enters At The Market Offering Agreement With H.C. Wainwright & Co.